,4 It has been demonstrated that CTHRC1 facilitates tumor initiation and progression by modulating the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway, thereby enhancing tumor dissemination, invasion, migration, adhesion, and metastasis.5 This evidence concerns the gene AKT1 and neoplasm.